Serum sclerostin is an independent predictor of mortality in hemodialysis patients

BACKGROUND: Sclerostin (Scl) has recently emerged as a novel marker of bone remodeling and vascular calcification. However, whether high circulating Scl is also a risk factor for death is not well established. The purpose of this study was to test whether serum Scl would be associated with mortality...

Cijeli opis

Spremljeno u:
Bibliografski detalji
Izdano u:BMC Nephrol
Glavni autori: Gonçalves, Flávia Letícia Carvalho, Elias, Rosilene M, dos Reis, Luciene M, Graciolli, Fabiana G, Zampieri, Fernando Godinho, Oliveira, Rodrigo B, Jorgetti, Vanda, Moysés, Rosa MA
Format: Artigo
Jezik:Inglês
Izdano: BioMed Central 2014
Teme:
Research Article
Online pristup:https://ncbi.nlm.nih.gov/pmc/articles/PMC4265422/
https://ncbi.nlm.nih.gov/pubmed/25465028
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1186/1471-2369-15-190
Oznake: Dodaj oznaku
Bez oznaka, Budi prvi tko označuje ovaj zapis!

Similar Items